Mary Barrett

1.2k total citations · 1 hit paper
7 papers, 923 citations indexed

About

Mary Barrett is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mary Barrett has authored 7 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mary Barrett's work include Prostate Cancer Treatment and Research (4 papers), Hormonal and reproductive studies (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Mary Barrett is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Hormonal and reproductive studies (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Mary Barrett collaborates with scholars based in United Kingdom and United States. Mary Barrett's co-authors include Johann S. de Bono, Gerhardt Attard, Stan B. Kaye, Mitch Dowsett, Timothy A. Yap, David P. Dearnaley, Florence I. Raynaud, Elizabeth Folkerd, J. W. Clark and Alison Reid and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Mary Barrett

7 papers receiving 907 citations

Hit Papers

Phase I Clinical Trial of a Selective Inhibitor of CYP17,... 2008 2026 2014 2020 2008 200 400 600

Peers

Mary Barrett
Natasja F. Dits Netherlands
Guangzhou Han United States
Shihua Sun United States
Vanessa Martins United Kingdom
Nikhil Babu Oommen United Kingdom
Stephanie Greene United States
Natasja F. Dits Netherlands
Mary Barrett
Citations per year, relative to Mary Barrett Mary Barrett (= 1×) peers Natasja F. Dits

Countries citing papers authored by Mary Barrett

Since Specialization
Citations

This map shows the geographic impact of Mary Barrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Barrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Barrett more than expected).

Fields of papers citing papers by Mary Barrett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Barrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Barrett. The network helps show where Mary Barrett may publish in the future.

Co-authorship network of co-authors of Mary Barrett

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Barrett. A scholar is included among the top collaborators of Mary Barrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Barrett. Mary Barrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Barrett, Mary, et al.. (2018). The Effect of Complementary Therapies on the Treatment of Chemotherapeutic Induced Nausea and Vomiting: A Systematic Review. 3 indexed citations
2.
Attard, Gerhardt, Alison Reid, Timothy A. Yap, et al.. (2008). Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven. Journal of Clinical Oncology. 26(28). 4563–4571. 666 indexed citations breakdown →
3.
Plummer, Ruth, Gerhardt Attard, Simon Pacey, et al.. (2007). Phase 1 and Pharmacokinetic Study of Lexatumumab in Patients with Advanced Cancers. Clinical Cancer Research. 13(20). 6187–6194. 198 indexed citations
4.
Attard, Gerhardt, Alison Reid, Rajesh Kumar Sinha, et al.. (2007). Selective inhibition of CYP17 with abiraterone acetate is well tolerated and results in a high response rate in castration-resistant prostate cancer (CRPC). Molecular Cancer Therapeutics. 6. 1 indexed citations
7.
Betts, Tim, et al.. (2003). Clinical experience of marketed Levetiracetam in an epilepsy clinic—a one year follow up study. Seizure. 12(3). 136–140. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026